| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations
|
Yao, Lu
|
|
2016
|
156 |
3 |
p. 441-445
|
artikel
|
| 2 |
Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry
|
Iwamoto, Takayuki
|
|
2016
|
156 |
3 |
p. 485-494
|
artikel
|
| 3 |
Erratum to: A novel vaccinia virus with dual oncolytic and anti-angiogenic therapeutic effects against triple-negative breast cancer
|
Gholami, Sepideh
|
|
2016
|
156 |
3 |
p. 607-608
|
artikel
|
| 4 |
Erratum to: FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells
|
Du, Juan
|
|
2016
|
156 |
3 |
p. 609-610
|
artikel
|
| 5 |
Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial
|
González-Rivera, Milagros
|
|
2016
|
156 |
3 |
p. 507-515
|
artikel
|
| 6 |
High use of complementary and alternative medicine among a large cohort of women with a family history of breast cancer: the Sister Study
|
Greenlee, Heather
|
|
2016
|
156 |
3 |
p. 527-538
|
artikel
|
| 7 |
Impact of genomic testing and patient-reported outcomes on receipt of adjuvant chemotherapy
|
Evans, Chalanda N.
|
|
2016
|
156 |
3 |
p. 549-555
|
artikel
|
| 8 |
Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions
|
Johns, Claire
|
|
2016
|
156 |
3 |
p. 415-426
|
artikel
|
| 9 |
Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up
|
Murtagh, G.
|
|
2016
|
156 |
3 |
p. 501-506
|
artikel
|
| 10 |
Medication use trajectories of postmenopausal breast cancer survivors and matched cancer-free controls
|
Pan, Kathy
|
|
2016
|
156 |
3 |
p. 567-576
|
artikel
|
| 11 |
MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer
|
Kim, Young-Ae
|
|
2016
|
156 |
3 |
p. 597-606
|
artikel
|
| 12 |
Neoadjuvant nab-paclitaxel in the treatment of breast cancer
|
Ueno, Naoto T.
|
|
2016
|
156 |
3 |
p. 427-440
|
artikel
|
| 13 |
Peri-operative biology in primary breast cancer: a credible therapeutic target
|
Love, Richard R.
|
|
2016
|
156 |
3 |
p. 411-413
|
artikel
|
| 14 |
Prediction of long-term cumulative incidences based on short-term parametric model for competing risks: application in early breast cancer
|
Cabarrou, B.
|
|
2016
|
156 |
3 |
p. 577-585
|
artikel
|
| 15 |
Prognostic factors in male breast cancer: a population-based study
|
Leone, José Pablo
|
|
2016
|
156 |
3 |
p. 539-548
|
artikel
|
| 16 |
Prognostic implication of the tumor location according to molecular subtypes in axillary lymph node-positive invasive ductal cancer in a Korean population
|
Lim, Seung Taek
|
|
2016
|
156 |
3 |
p. 473-483
|
artikel
|
| 17 |
Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer
|
Greenlee, Heather
|
|
2016
|
156 |
3 |
p. 453-464
|
artikel
|
| 18 |
Risk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort study
|
Roozendaal, Lori M. van
|
|
2016
|
156 |
3 |
p. 465-472
|
artikel
|
| 19 |
SEARCHBreast: a new resource to locate and share surplus archival material from breast cancer animal models to help address the 3Rs
|
Blyth, Karen
|
|
2016
|
156 |
3 |
p. 447-452
|
artikel
|
| 20 |
Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy
|
Roozendaal, L. M. van
|
|
2016
|
156 |
3 |
p. 517-525
|
artikel
|
| 21 |
Structured reporting ensures complete content and quick detection of essential data in pathology reports of oncological breast resection specimens
|
Aumann, Konrad
|
|
2016
|
156 |
3 |
p. 495-500
|
artikel
|
| 22 |
The incidence of bone metastasis after early-stage breast cancer in Canada
|
Liede, Alexander
|
|
2016
|
156 |
3 |
p. 587-595
|
artikel
|
| 23 |
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
|
Drooger, Jan C.
|
|
2016
|
156 |
3 |
p. 557-566
|
artikel
|
Tijdschrift beschrijving